What We Need From You Sample Clauses

What We Need From You. By executing and delivering this letter, you hereby agree:

What We Need From You. By executing and delivering this letter, you will hereby agree to automatically convert, upon closing of the Offering (the “Automatic Conversion”), the Note Obligation into shares of common stock of the Company at a conversion price equal to the price per share of common stock paid by the investors in the Offering (the “Conversion Price”). Upon the triggering of Automatic Conversion, the Company shall send you prompt written notice (the “Automatic Conversion Notice”) specifying the Conversion Price and date upon which such conversion was effective (the “Effective Date”). The Automatic Conversion Notice will also contain instructions on surrendering to the Company your original Note; provided, however, the Automatic Conversion shall be effective on the Effective Date whether or not you surrender the Note, which shall be null and void on the Effective Date. In addition, the Note Obligation will increase based on accrued interest in the event the Automatic Conversion occurs after June 30, 2017.

What We Need From You. For Monthly Bookkeeping Services, you will be required to login to your bank thru QuickBooks Online. We WILL NOT have access to your money. We will NOT have a record of your password. This will only allow us to download the exact same information that we could see on the bank statements. The only way we can offer discounted prices is to automate our processes. Call if you have questions about this. Also, during initial set up, we will need to obtain items such as (if available) your existing QuickBooks data file (or similar software) and supporting documents such as check registers, bank statements, uncollected customer invoices, sales ledgers & receipts, purchase orders & unpaid vendor invoices (aka “bills”), and complete payroll information. Other items needed by us include ‘answers to our questions’ and ‘any other information’ that we may require to complete the work of this engagement. These items and any other items that we obtain from you will be based on information provided by you and will be used without any further verification or investigation on our part. See also the New Client Checklist included. We must receive your bank statements as soon as possible with check images. If we cannot tell who the check is payable to, we will need to get that information. NOTE: Again online access to bank accounts, are a requirement for the discounted rates of this proposal. If manual data entry is required, it will be billed at our clerical hourly rate. This will be communicated to you in advanced of the work being done. We will reconcile your bank and investment accounts (up to 5). Process your sales tax report and payment(s). Review your payroll reports from QBO or other payroll processor and make adjustments to the accounting records as needed. Review and deliver pdf’s of monthly financial statements to you by the 20th via email. We will be your business coach to help you achieve long term success by offering 1 hour per month (non-cumulative) of addition accounting work, consulting, or clerical service. Just call. Reports as needed for loan applications. Long-term budgeting and (for management only) forecasting. Reporting to Boards Prepare annual financial statements by March 1st of each year. Issue any annual 1099’s and the annual property tax rendering. W-2, W-3, 941, 940, and State U/E reporting will be done by QB Payroll. We will be your business coach to help you achieve long term success by offering 1 hour per month of addition accounting work, consu...

What We Need From You. 3.1 You understand that the Services we provide aim to reduce and help to manage your symptoms. 3.2 You agree that you have told us about all relevant medical issues which you are now suffering from or have in the past suffered from, and all medication which you are taking. You agree that if, whilst we are treating you, you suffer any significant medical issues, take a course of medication or are given medical treatment you will inform us of this. You understand that this information is important because we take it into account when designing an appropriate treatment for you. 3.3 If any of these Terms are inconsistent with the Customer Order Form, the Terms shall prevail. 3.4 We have the right to revise and amend these Terms from time to time to reflect changes in market conditions affecting our business, changes in technology, changes in payment methods and changes in relevant laws and regulatory requirements. If the revision affects your Contract, we will notify you in writing of these changes before applying them. These changes will not however allow us to perform the Contract in a manner which is substantially different from what you reasonably expected or to not perform our obligations in the Contract at all or to exclude or restrict any of our liability for our own breach of the Contract. 3.5 We understand unexpected events may mean you need to change an appointment date. You must give us at least 48 hours notice if you need to postpone an appointment or we may charge you and we may ask for payment in advance of any rescheduled appointment which we arrange for you. 3.6 You agree that we may write to your GP or other physician treating you to ask for relevant medical information about you and/ or to provide them with relevant medical information. Where you do not agree to us writing to your GP or other physician, we may not agree to treat you. Whether or not we have contacted your GP we cannot be held liable for any effects or damage which arise as a result of our not having been fully informed about any of your medical condition(s).

What We Need From You. By executing and delivering this letter, you agree to accept shares of the Company’s restricted common stock as described below in exchange for all outstanding Warrants and Series D Preferred shares. As of April 19, 2021 our records indicate that you own Warrants entitling you to purchase _____ shares of Common Stock and have rights to ______ shares of Common Stock based on your ownership of _____ Series D Preferred Shares at the current conversion price of $1.60. You hereby agree by your signing of this Letter Agreement to automatically exchange your Warrants to purchase _____ shares of Common Stock into ______ restricted shares of Common Stock upon the closing of the Offering (the “Automatic Warrant Conversion”). Within ten (10) business days of the closing date of the Offering, the Company shall send you instructions on surrendering to the Company your original Warrants; provided, however, the Automatic Warrant Conversion shall be effective on the date of the closing of the Offering, whether or not you surrender your original Warrants, which shall be null and void on such date. You also hereby agree by your signing of this Letter Agreement to automatically convert your ____ Series D Preferred Shares into ____ restricted shares of Common Stock upon the closing of the Offering (the “Automatic Preferred Conversion”). Within ten (10) business days of the date of the closing of the Offering, the Company shall send you instructions on surrendering to the Company the certificate representing you Series D Preferred Shares; provided, however, the Automatic Preferred Conversion shall be effective on the date of the closing of the Offering whether or not you surrender such certificates, which shall be null and void on such date. All shares being issued pursuant to this Letter Agreement are being issued pursuant to an exemption from registration afforded by Section 4(a)(2) of the Securities Act of 1933, as amended (the “1933 Act”), and Rule 506(b) of Regulation D (“Regulation D”) as promulgated by the SEC. By your agreement and acknowledgment below, this Letter Agreement shall serve as written confirmation that:

What We Need From You. By executing and delivering this letter, you will hereby agree to automatically convert upon the closing of the Company’s Offering (the “Conversion”), your Note Obligation into shares of the Company’s common stock at a $0.20 conversion price, for example, if your Note Obligation is equal to $100,000, you would receive 500,000 shares of Common Stock and an Incentive Warrant to purchase 250,000 shares of Common Stock at the exercise price of $0.30 per share. By your agreement and acknowledgment below, this Letter Agreement shall serve as written confirmation that:

What We Need From You. By executing and delivering this letter, you will hereby agree to automatically convert upon the closing of the Company’s Offering (the “Conversion”), your <<SeriesB>> shares of Series B Preferred Stock into <<CommonB>> shares of the Company’s common stock at a $0.19683 per share conversion price (the “Conversion Price”). In addition, pursuant to the Conversion, you will receive 0 shares of Common Stock as payment for accrued and unpaid dividends, from the date of inception of the Company through August 15, 2018 amounting to $0, owed pursuant to your ownership of the shares of Series B Preferred Stock and converted hereunder. You will also receive an Incentive Warrant to purchase <<Incentive Warrant>> shares of Common Stock at the exercise price of $0.30 per share. To effect the Conversion and issuance of the Incentive Warrant, the Company requests that you (i) complete and execute the enclosed Notice of Conversion (“Notice of Conversion”); (ii) send scanned copies of the executed Notice of Conversion to the Company; (iii) send to the Company, originally executed copies of the Notice of Conversion, together with your original Series B Preferred Stock certificate By your agreement and acknowledgment below, this Letter Agreement shall serve as written confirmation that:

What We Need From You. By executing and delivering this letter you will hereby agree to automatically convert upon closing of the Offering (the "Automatic Conversion"), your 25,000 shares of Series D Preferred Stock into Common Stock of the Company, based on their redemption value of $300,000, at a conversion price equal to $0.045 per share (the "Conversion Price") resulting in the issuance of 6,666,666 shares of Common Stock, subject to adjustment only for the contemplated reverse stock split. Upon the triggering of Automatic Conversion, the Company shall send you prompt written notice (the "Automatic Conversion Notice") specifying the date upon which such conversion was effective (the "Effective Date"). The Automatic Conversion Notice will also contain instructions on surrendering to the Company the certificate or certificates (the "Certificates"), if applicable, representing the 25,000 shares of Series D Preferred owned by you, however, the Automatic Conversion shall be effective on the Effective Date whether or not you surrender the Certificates, which shall be null and void on the Effective Date.

What We Need From You. As of March 31, 2017 our records indicate that you own 10,000,000 Series A Preferred shares which are convertible into 25,000,000 shares of Common Stock. Under the terms of the Series A Preferred Stock Certificate of Designation, as amended, the Reverse Split will not result in a proportionate adjustment to the conversion ratio of the Series A Preferred Stock. By executing and delivering this Letter Agreement, you agree that, upon the Company’s implementation of the Reverse Split, your 25,000,000 (as converted) shares of Common Stock will be reduced to 2,000,000 shares of Common Stock (the “Reverse Split Reduction”). In addition, by executing and delivering this Letter Agreement, you agree to accept shares of restricted common stock as described below as full compensation for all outstanding Series A Preferred shares, and any other amounts owed to you under any compensation associated with the Transaction Documents or any other agreements not referenced that may provide you with any rights to Series A Preferred shares. You hereby agree to automatically convert upon closing of the Offering (the “Automatic Preferred Conversion”), your Series A Preferred shares into 2,000,000 restricted shares of Common Stock. Upon the triggering of the Automatic Preferred Conversion, the Company shall send you prompt written notice (the “Automatic Preferred Conversion Notice”) specifying the date upon which such conversion was effective (the “Effective Date”) and the number of restricted shares of Common Stock to be issued to you upon conversion. The Automatic Preferred Conversion Notice will also contain instructions on surrendering to the Company your original Series A Preferred share certificates; provided, however, the Automatic Preferred Conversion shall be effective on the Effective Date whether or not you surrender your original Series A Preferred share certificates, which shall be null and void on the Effective Date. By your agreement and acknowledgment below, this Letter Agreement shall serve as written confirmation that:

What We Need From You. By executing and delivering this letter, you agree to accept shares of the Company’s restricted common stock as described below in exchange for all Series [E][F] Preferred Shares that you own. As of April 13, 2021 our records indicate that you have the right to ________ shares of Common Stock based on your ownership of ________ shares of Series E Preferred Shares at the current conversion price of $1.6. You hereby agree by your signing of this Letter Agreement to automatically convert your ________ shares of Series E Preferred Stock into ________ restricted shares of Common Stock upon the occurrence of the closing of the Offering (the “Automatic Preferred Conversion”). Within ten (10) business days of the date of the closing of the Offering, the Company shall send you instructions on surrendering to the Company the certificate(s) representing you Series E Preferred Shares; provided, however, the Automatic Preferred Conversion shall be effective on the date of the closing of the Offering whether or not you surrender such certificates, which shall be null and void on such date. All shares being issued pursuant to this Letter Agreement are being issued pursuant to an exemption from registration afforded by Section 4(a)(2) of the Securities Act of 1933, as amended (the “1933 Act”), and Rule 506(b) of Regulation D (“Regulation D”) as promulgated by the SEC. By your agreement and acknowledgment below, this Letter Agreement shall serve as written confirmation that: